Multiomics reveals the role of ENO1 in bladder cancer and constructs an epithelial-related prognostic model to predict prognosis and efficacy DOI Creative Commons
Zhixiong Su,

Lijie You,

Yufang He

и другие.

Research Square (Research Square), Год журнала: 2023, Номер unknown

Опубликована: Сен. 27, 2023

Abstract Background α-Enolase (ENO1) is a crucial molecular target for tumor therapy and has emerged as research hotspot in recent decades. Here, we aimed to explore the role of ENO1 bladder cancer (BLCA) then construct signature predict prognosis treatment response BLCA. Methods Differential expression, analysis vitro cell experiments were used reveal value The R package "Seurat" was single-cell RNA sequence (scRNA-seq) data processing. “singleR” cellMarker website annotate cells. FindAllMarkers function “limma” screen hub genes. Univariate Cox least absolute shrinkage selection operator (LASSO) analyses signature. Differences between high- low-risk groups investigated. Results highly expressed BLCA tissues, verified by IHC, associated with poor prognosis. immune microenvironment bulk sequencing scRNA-seq showed that CD8 + T-cell exhaustion. Additionally, results could promote proliferation invasion Then, epithelial cells (ECs) revealed might progression metabolism, cycle some carcinogenic pathways. A total 249 genes obtained from differentially ENO1-related ECs, LASSO novel not only accurately predicted patients but also Finally, constructed nomogram better guide clinical application. Conclusion Through multiomics analysis, found overexpressed prognosis, exhaustion heterogeneity. can be well constructing an prognostic

Язык: Английский

ENO1 deletion potentiates ferroptosis and decreases glycolysis in colorectal cancer cells via AKT/STAT3 signaling DOI Open Access
Ying Liu,

Yinyin Hou,

Fan Zhang

и другие.

Experimental and Therapeutic Medicine, Год журнала: 2024, Номер 27(4)

Опубликована: Фев. 5, 2024

Colorectal cancer (CRC) is one of the most prevailing and lethal forms globally. α‑enolase (ENO1) has been well documented to be involved in progression drug resistance CRC. The present study was designed specify role ENO1 major events during process CRC introduce its latent functional mechanism. expression determined by western blot analysis. Extracellular acidification rates were assessed using an XF96 extracellular flux analyzer. Glucose uptake, lactic acid production, total iron levels ferroptosis‑related markers examined with corresponding kits. A dichlorodihydrofluorescein diacetate probe measured intracellular reactive oxygen species content. Western blotting detected glycolysis‑ proteins. CCK‑8 EdU staining assays cell proliferation. In current study, highly expressed cells. Knockdown markedly reduced glycolysis accelerated ferroptosis Moreover, inhibitory effects WZB117, a specific inhibitor glycolysis‑related glucose transporter type 1, on proliferation further enhanced interference. addition, silencing inactivated AKT/STAT3 signaling. AKT activator SC79 partially reversed deficiency signaling, glycolysis, as summary, inactivation signaling mediated inhibition might boost suppress

Язык: Английский

Процитировано

8

Multi-omics reveals the role of ENO1 in bladder cancer and constructs an epithelial-related prognostic model to predict prognosis and efficacy DOI Creative Commons
Zhixiong Su,

Lijie You,

Yufang He

и другие.

Scientific Reports, Год журнала: 2024, Номер 14(1)

Опубликована: Янв. 25, 2024

Abstract α-Enolase ( ENO1 ) is a crucial molecular target for tumor therapy and has emerged as research hotspot in recent decades. Here, we aimed to explore the role of bladder cancer (BLCA) then construct signature predict prognosis treatment response BLCA. Firstly, found was highly expressed BLCA tissues, verified by IHC, associated with poor prognosis. The analysis immune microenvironment bulk RNA-seq scRNA-seq showed that CD8+ T-cell exhaustion. Additionally, results vitro could promote proliferation invasion cells. Then, epithelial cells (ECs) revealed might progression metabolism, cell cycle some carcinogenic pathways. A total 249 hub genes were obtained from differentially between -related ECs, used LASSO novel not only accurately predicted patients but also Finally, constructed nomogram better guide clinical application. In conclusion, through multi-omics analysis, overexpressed prognosis, exhaustion heterogeneity. Moreover, can be well constructing an epithelial-related prognostic signature.

Язык: Английский

Процитировано

3

CDCA3-MYC positive feedback loop promotes bladder cancer progression via ENO1-mediated glycolysis DOI Creative Commons

Dexin Shen,

Xiang Yu, Xuefeng Fan

и другие.

Journal of Experimental & Clinical Cancer Research, Год журнала: 2025, Номер 44(1)

Опубликована: Фев. 20, 2025

Язык: Английский

Процитировано

0

Targeting the JAK2–STAT3–UCHL3–ENO1 axis suppresses glycolysis and enhances the sensitivity to 5-FU chemotherapy in TP53-mutant colorectal cancer DOI Creative Commons

Haisong Xin,

Zitong Zhao,

Shichao Guo

и другие.

Acta Pharmaceutica Sinica B, Год журнала: 2025, Номер unknown

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

0

Warburg effect and lactylation in cancer: mechanisms for chemoresistance DOI Creative Commons
Wenjie Zhang, Min Xia, Jiahui Li

и другие.

Molecular Medicine, Год журнала: 2025, Номер 31(1)

Опубликована: Апрель 22, 2025

Abstract In the clinical management of cancers, emergence chemoresistance represents a profound and imperative “pain point” that requires immediate attention. Understanding mechanisms is essential for developing effective therapeutic strategies. Importantly, existing studies have demonstrated glucose metabolic reprogramming, commonly referred to as Warburg effect or aerobic glycolysis, major contributor chemoresistance. Additionally, lactate, byproduct functions signaling molecule supports lysine lactylation modification proteins, which also plays critical role in However, it insufficient discuss glycolysis from single perspective. The intricate relationship between crucial promoting Thus, thorough elucidation underlying mediated by essential. This review provides comprehensive overview these further outlines exert synergistic effects, development creating positive feedback loop continues mediate this resistance. close link suggests application glycolysis-related drugs inhibitors cancer therapy may represent promising anticancer strategy. Furthermore, targeted lactylation, either alone combination with other treatments, offer new avenues overcoming

Язык: Английский

Процитировано

0

Autophagy/ferroptosis in colorectal cancer: Carcinogenic view and nanoparticle-mediated cell death regulation DOI
Zhibin Zhang,

Yintao Zhao,

Yuman Wang

и другие.

Environmental Research, Год журнала: 2023, Номер 238, С. 117006 - 117006

Опубликована: Сен. 3, 2023

Язык: Английский

Процитировано

8

Role of ENO1 and its targeted therapy in tumors DOI Creative Commons
Yafei Li, Lu Liu, Bo Li

и другие.

Journal of Translational Medicine, Год журнала: 2024, Номер 22(1)

Опубликована: Ноя. 14, 2024

ENO1, also called 2-phospho-D-glycerate hydrolase in cellular glycolysis, is an enzyme that converts 2-phosphoglycerate to phosphoenolpyruvate and plays important role the Warburg effect. In various tumors, ENO1 overexpression correlates with poor prognosis. a multifunctional oncoprotein that, when located on cell surface, acts as "moonlighting protein" promote tumor invasion metastasis. When intracellularly, facilitates glycolysis dysregulate energy sustain proliferation. Additionally, it promotes progression by activating oncogenic signaling pathways. biomarker represents promising target for therapy. This review summarizes recent advances from 2020 2024 understanding relationship between tumors explores latest targeted therapeutic strategies involving ENO1.

Язык: Английский

Процитировано

2

Robust self-supervised learning strategy to tackle the inherent sparsity in single-cell RNA-seq data DOI Creative Commons
Se Jin Park, Hyunju Lee

Briefings in Bioinformatics, Год журнала: 2024, Номер 25(6)

Опубликована: Сен. 23, 2024

Abstract Single-cell RNA sequencing (scRNA-seq) is a powerful tool for elucidating cellular heterogeneity and tissue function in various biological contexts. However, the sparsity scRNA-seq data limits accuracy of cell type annotation transcriptomic analysis due to information loss. To address this limitation, we present scRobust, robust self-supervised learning strategy tackle inherent data. Built upon Transformer architecture, scRobust employs novel comprising contrastive gene expression prediction tasks. We demonstrated effectiveness using nine benchmarks, additional dropout scenarios, combined datasets. outperformed recent methods cell-type tasks generated embeddings that capture multi-faceted clustering (e.g. types HbA1c levels). In addition, were useful detecting specific marker genes related drug tolerance stages. Furthermore, when applied scATAC-seq data, high-quality embedding vectors generated. These results demonstrate representational power scRobust.

Язык: Английский

Процитировано

2

ARNTL2 facilitates bladder cancer progression through potentiating ENO1-mediated glycolysis in a SLC31A1-independent and -dependent manner DOI
Jiahao Wang, Junwei Ren,

Xiang Tu

и другие.

Life Sciences, Год журнала: 2024, Номер 355, С. 122974 - 122974

Опубликована: Авг. 13, 2024

Язык: Английский

Процитировано

1

Exploring the role of estrogen and progestins in breast cancer: A genomic approach to diagnosis DOI

Prasanna Kumar Selvam,

Santhosh Mudipalli Elavarasu,

T Dhanushkumar

и другие.

Advances in protein chemistry and structural biology, Год журнала: 2024, Номер unknown

Опубликована: Янв. 1, 2024

Язык: Английский

Процитировано

0